SB-265610

SB-265610
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T16850-1mg 1 mg -

7 - 10 business days*

51.00€
TGM-T16850-5mg 5 mg -

7 - 10 business days*

119.00€
TGM-T16850-1mL 1 ml -

7 - 10 business days*

130.00€
TGM-T16850-10mg 10 mg -

7 - 10 business days*

192.00€
TGM-T16850-25mg 25 mg -

7 - 10 business days*

387.00€
TGM-T16850-50mg 50 mg -

7 - 10 business days*

577.00€
TGM-T16850-100mg 100 mg -

7 - 10 business days*

826.00€
TGM-T16850-500mg 500 mg -

7 - 10 business days*

1,697.00€
 
Description: SB-265610 (GSK-CXCR2) is a nonpeptide and allosteric CXCR2 antagonist. SB-265610... more
Product information "SB-265610"
Description: SB-265610 (GSK-CXCR2) is a nonpeptide and allosteric CXCR2 antagonist. SB-265610 blocks rat cytokine-induced neutrophil chemoattractant-1 (CINC-1)-induced calcium mobilization and neutrophil chemotaxis (IC50s: 3.7 nM and 70 nM, respectively). Target: CXCR. Smiles: Brc1ccccc1NC(=O)Nc1ccc(C#N)c2nn[nH]c12. References: Auten RL, et al. Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxia-exposed newborn rats. J Pharmacol Exp Ther. 2001 Oct,299(1):90-5.
Keywords: GSK-CXCR2
Supplier: TargetMol
Supplier-Nr: T16850

Properties

Application: Allosteric, inverse CXCR2 agonist
MW: 357.16 D
Formula: C14H9BrN6O

Database Information

CAS : 211096-49-0| Matching products
KEGG ID : K05050 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Signal Word: Warning
GHS Hazard Pictograms:
H Phrases: H302
P Phrases: P264, P270, P301+310, P330, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "SB-265610"
Write a review
or to review a product.
Viewed